F40 F41
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: For trial participation the patients had to fulfil the inclusion criteria by 1) been diagnosed with an anxiety disorder by a physician (ICD-10 conform) and 2) currently participating in psychotherapeutic sessions.
Exclusion criteria
Exclusion criteria: Within the exclusion criteria the patients weren´t allowed to be diagnosed with a disorder affecting facial expression 1) reductively like morbus parkinson, apraxia, autism, facial nerve paresis and spasm or 2) increasingly like huntington´s disease, west syndrome, schizophrenia and motor tics.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quantitative evaluation of the trial procedure, interventions, eligibility criteria, acquisition, harms and statistics took place after the follow-up. | — |
Secondary
| Measure | Time frame |
|---|---|
| Qualitative evaluation of anxiety using the Beck Anxiety Inventory (BAI) and Numeric Rating Scale (NRS) took place before every treatment session and in the follow-up. The performance of a power analysis for planning of full-scale study took place after the follow-up. | — |
Countries
Germany
Contacts
Osteopathie Schule Deutschland